| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.15 | 0.4 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.14 | 0.4 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.042 | 0.4 |